📰 Pharma Services News
Page 17 - Pharma Services News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Services. Real-time updates on events, politics, business and more.
May 15, 2023
NeoGenomics (NASDAQ:NEO – Get Rating) had its price target lifted by equities research analysts at Piper Sandler from $20.00 to $23.00 in a research report issued to clients and investors on Monday, The Fly reports. Piper Sandler’s target price suggests a potential upside of 18.86% from the stock’s previous close. NEO has been the topic […]
May 15, 2023
NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) was the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 7,080,000 shares, an increase of 12.7% from the April 15th total of 6,280,000 shares. Based on an average daily volume of 1,250,000 shares, the short-interest […]
May 15, 2023
NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 7,080,000 shares, an increase of 12.7% from the April 15th total of 6,280,000 shares. Based on an average trading volume of 1,250,000 shares, the short-interest ratio is currently […]
May 11, 2023
/PRNewswire/ -- The pharmaceutical contract manufacturing market size is set to grow by USD 58 billion from 2022 to 2027 progressing at a CAGR of 7.81% during...
May 10, 2023
NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) reached a new 52-week high on Wednesday . The stock traded as high as $19.65 and last traded at $19.44, with a volume of 767276 shares. The stock had previously closed at $18.25. Analysts Set New Price Targets Several analysts have recently weighed in on NEO shares. Raymond James […]
May 10, 2023
Operator: Hello and welcome to the Fulgent Genetics Q1 2023 Earnings Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
May 7, 2023
NeoGenomics (NASDAQ:NEO – Get Rating) will be issuing its quarterly earnings data after the market closes on Monday, May 8th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. NeoGenomics has set its FY 2023 guidance at -$0.38–$0.32 EPS.Persons interested in registering for the company’s earnings conference call can do […]
May 2, 2023
Dennis Huang is one of the recently added board executives for the Council, which oversees over 1,600 health care industry organizations.
May 1, 2023
TORONTO, May 1, 2023 /CNW/ - Think Research Corporation , a company focused on transforming healthcare through digital health software solutions, is pleased to announce that it has entered into an... | May 1, 2023
April 29, 2023
Nisa Investment Advisors LLC raised its stake in NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) by 5.0% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 52,124 shares of the medical research company’s stock after acquiring an additional 2,500 shares during the period. Nisa Investment Advisors LLC’s holdings in NeoGenomics were worth $482,000 as of […]